Scientists have successfully engineered the most complicated human cell lines ever indicating that our genomes are more tolerant to significant structural alte ...

In 2019, the first CRISPR clinical trials were conducted to treat sickle cell diseases and in 2020, this treatment was ...

After more than a decade of work, researchers have reached a major milestone in their efforts to re-engineer life in the lab, putting together the final chromosome in a synthetic yeast (Saccharomyces ...

Secret doors, smoke plumes, air locks, a million species and shipwrecked treasures: this world-renowned Sydney establishment could be the most biodiverse spot in the country.

Repare Therapeutics Inc. (NASDAQ:RPTX – Get Free Report) was the recipient of a significant decrease in short interest in January. As of January 15th, there was short interest totalling 1,130,000 ...